Creative Details

Quality Score: 8/10

The advertisement promotes Cosentyx, encouraging healthcare professionals to prescribe it as a first-line treatment.

Creative Information

CID:faa0ac0c-d790-4a11-9b30-5c7d2c586fcb
CRID:2_206_451484
Domain:novartis.com
Seat:BSW
Size:320x50
Bid:$8.00
Timestamp:10/30/2025, 2:19:49 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess10/31/2025, 1:45:46 AM5.02s
    adomain_analysissuccess10/31/2025, 1:45:47 AM3.71s
    adomain_capturesuccess10/31/2025, 1:45:43 AM0.24s
    ad_rendersuccess10/30/2025, 3:38:43 PM16.12s
    brand_mappingsuccess10/31/2025, 12:57:02 AM0.14s

    Analysis Results

    Ad Format: banner

    Brands: Novartis

    Sensitive:Pharmaceutical Products
    Size:320x50
    Data Transferred:633.77 KB
    Render Time:7.30 Seconds
    Creative Inferred IAB Categories:
    • Business (IAB3)
    • Health & Fitness (IAB7)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Business (IAB3)
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Total Ad Size:673.96 KB
    Requests Made:
    URLSize (KB)
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js?cache=r20110914221.47
    https://ad.doubleclick.net/ddm/adj/N7437.2055741ADTHEORANT/B32942337.409684614;dc_ver=106.314;dc_eid=40004000;sz=320x50;u_sd=1;gdpr_consent=AUDIT;nel=1;kw=089f8b53-b412-11f0-9544-12e3256efa57;dc_adk=2027040031;ord=zyz874;click=https%3A%2F%2Frtb.adentifi.com%2FClicks%3FcrId%3D451484%3BsId%3D772725%3BlId%3D91969%3BcId%3D17953%3BadExchange%3DBidSwitch%3Baction%3Dclick%3BadId%3D089f8b53-b412-11f0-9544-12e3256efa57%3BadThdId%3Deae43038a368629d8e3618f9b032cd96%3BengineId%3Di-0ec174e272ced253c%3BdIp%3DNTAuODEuMjMxLjE0OA%3BdIpv6%3D%3BadThdIdCode%3DWEB_MD5_V4%3BdealId%3D0%3BgeoId%3D67518%3BinventoryId%3D718417359%3BrtdmIndicator%3D1%3Btimestamp%3D1761664999%3Blat%3DNDEuNjU%3Blong%3DLTkxLjU3%3Bdma%3DNjM3%3BstateCode%3D%3Bzip%3DNTIyNDY%3Bbsc%3DAUDIT%3Bredir%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=8IHzs-oC3A;gcsr=m;stc=1;chaa=1;sttr=36;prcl=s75.57
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://cdn.doubleverify.com/dvbs_src_internal140.js63.65
    https://ep1.adtrafficquality.google/bg/d_CiwsBz4C1JnuQWQa80FmGcfeOOSGcvq61yBJQq_4U.js52.61
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74
    https://choices.truste.com/ca?pid=publicishealthmedia01&aid=novartispharma01&cid=32942337_234857905_409684614&js=st025.33
    https://s0.2mdn.net/simgad/496872245505751723123.33
    https://choices.truste.com/ca?pid=adtheorent01&aid=adtheorent01&cid=17953&c=adtheorent01cont451484&w=320&h=50&js=pmw0&plc=tr&uid=eae43038a368629d8e3618f9b032cd9621.11
    https://choices.trustarc.com/get?name=pmw2.js19.05

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Raw Ad Markup

    <script type="text/adtag"><ins class='dcmads' style='display:inline-block;width:320px;height:50px'    data-dcm-placement='N7437.2055741ADTHEORANT/B32942337.409684614'    data-dcm-rendering-mode='script'    data-dcm-https-only    data-dcm-keywords='089f8b53-b412-11f0-9544-12e3256efa57'    data-dcm-click-tracker='https%3A%2F%2Frtb.adentifi.com%2FClicks%3FcrId%3D451484%3BsId%3D772725%3BlId%3D91969%3BcId%3D17953%3BadExchange%3DBidSwitch%3Baction%3Dclick%3BadId%3D089f8b53-b412-11f0-9544-12e3256efa57%3BadThdId%3Deae43038a368629d8e3618f9b032cd96%3BengineId%3Di-0ec174e272ced253c%3BdIp%3DNTAuODEuMjMxLjE0OA%3BdIpv6%3D%3BadThdIdCode%3DWEB_MD5_V4%3BdealId%3D0%3BgeoId%3D67518%3BinventoryId%3D718417359%3BrtdmIndicator%3D1%3Btimestamp%3D1761664999%3Blat%3DNDEuNjU%3Blong%3DLTkxLjU3%3Bdma%3DNjM3%3BstateCode%3D%3Bzip%3DNTIyNDY%3Bbsc%3D${CLICK_URL_ENC}%3Bredir%3D'        data-dcm-resettable-device-id=''    data-dcm-api-frameworks='[APIFRAMEWORKS]'    data-dcm-omid-partner='[OMIDPARTNER]'    data-dcm-gdpr-applies='gdpr=${GDPR}'    data-dcm-gdpr-consent='gdpr_consent=${GDPR_CONSENT_755}'    data-dcm-addtl-consent='addtl_consent=${ADDTL_CONSENT}'    data-dcm-ltd='false'    data-dcm-app-id=''>  <script src='https://www.googletagservices.com/dcm/dcmads.js'></scr+ipt></ins></script><script language="javascript" type="text/javascript" src="https://cdn.doubleverify.com/dvbs_src.js?ctx=17025832&cmp=32942337&plc=409684614&sid=4348720&dvregion=0&unit=320x50"></script><img src='https://rtb.adentifi.com/Imps?impId=1;adId=089f8b53-b412-11f0-9544-12e3256efa57;lId=91969;sId=772725;cId=17953;crId=451484;adThdId=eae43038a368629d8e3618f9b032cd96;adExchange=BidSwitch;engineId=i-0ec174e272ced253c;dealId=0;geoId=67518;inventoryId=718417359;rtdmIndicator=1;timestamp=1761664999;property=hawkeyeswire.usatoday.com;dIp=NTAuODEuMjMxLjE0OA;dIpv6=;adThdIdCode=WEB_MD5_V4;thirdPartyIdType=1;npiKey=1843463124852772510;hhId=0;cuid=cuid_b30c5ab1-9c0b-11f0-8f35-121a3bdf91f3' style='display:none; width:0px; height:0px;' /><script src="https://tags.bkrtx.com/js/bk-coretag.js"></script><script>bk_addPageCtx("id","cuid_b30c5ab1-9c0b-11f0-8f35-121a3bdf91f3");bk_allow_multiple_calls = true;bk_use_multiple_iframes = true;bk_send_statid_payload = true;bk_use_image = true;bk_callback = true;bk_doJSTag(18840, 4);</script><img src='https://sb.scorecardresearch.com/p?c1=9&c2=16077523&c3=2&cs_xi=cuid_b30c5ab1-9c0b-11f0-8f35-121a3bdf91f3&rn=089f8b53-b412-11f0-9544-12e3256efa57' height='0' width='0' /><span id="te-clearads-js-adtheorent01cont451484"><script type="text/javascript" src="//choices.truste.com/ca?pid=adtheorent01&aid=adtheorent01&cid=17953&c=adtheorent01cont451484&w=320&h=50&js=pmw0&plc=tr&uid=eae43038a368629d8e3618f9b032cd96"></script></span><img src="https://us-east-sync.bidswitch.net/sync?ssp=kargo&amp;dsp_id=206&amp;imp=1" alt=" " style="display:none"/>

    Creatives

    Creative Screenshot 1